The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.
Also known as: Liver Kidney Microsome Lkm1 Ab IgG
The Liver Kidney Microsomal (LKM-1) Antibody (IgG) test contains 1 test with 1 biomarker.
Brief Description: The Liver Kidney Microsomal (LKM) IgG Antibody test is a blood test that detects the presence of antibodies against specific components, primarily located within the cells of the liver and kidney. These antibodies are autoantibodies, meaning they target and can potentially harm the body's own cells.
Collection Method: Blood Draw
Specimen Type: Serum
Test Preparation: No preparation required
The test may be ordered when an individual presents with signs or symptoms of liver damage or autoimmune liver disease, such as:
It is particularly ordered when a healthcare provider suspects Type 2 Autoimmune Hepatitis, as LKM antibodies are often found in this condition.
The Liver Kidney Microsomal IgG Antibody test checks for the presence of these specific autoantibodies in the blood. The presence of these antibodies may indicate an autoimmune disorder affecting the liver.
When a Liver Kidney Microsomal IgG Antibody test is ordered, it's typically part of a broader evaluation of liver health and autoimmune disorders. Here are some tests commonly ordered alongside it:
Anti-Smooth Muscle Antibody (ASMA):
Antinuclear Antibody (ANA) Test:
Immunoglobulin Levels (IgG, IgA, IgM):
Complete Blood Count (CBC) with Differential:
Viral Hepatitis Panel (Hepatitis A, B, and C Serologies):
Albumin and Prothrombin Time:
These tests, when ordered alongside a Liver Kidney Microsomal IgG Antibody test, provide a comprehensive evaluation of liver health and help in diagnosing autoimmune hepatitis and other liver conditions. They are crucial for differentiating between various causes of liver disease, assessing the extent of liver damage, and guiding treatment and management decisions. The specific combination of tests will depend on the individual’s symptoms, clinical history, and the suspected underlying condition.
The presence of Liver Kidney Microsomal antibodies in the blood can provide a strong indication of Type 2 Autoimmune Hepatitis. If the test results are positive:
A negative test doesn't rule out liver disease but may point the healthcare provider to consider other potential causes of liver dysfunction. As with all diagnostic tests, results are interpreted in the context of the patient's clinical presentation and other laboratory findings.
Why is the Liver Kidney Microsomal IgG Antibody test ordered?
The Liver Kidney Microsomal IgG Antibody test is primarily ordered to help diagnose autoimmune hepatitis type 2 (AIH type 2), a type of liver inflammation caused by the immune system attacking the liver. This test helps to differentiate AIH type 2 from other types of liver disorders and helps to guide treatment decisions.
How does the Liver Kidney Microsomal IgG Antibody test differ from other liver tests?
The Liver Kidney Microsomal IgG Antibody test specifically identifies antibodies against liver and kidney microsomes, which are indicative of AIH type 2. Other liver tests might measure liver enzymes, proteins, or other antibodies to assess liver function or diagnose different liver conditions. This test is more specific for an autoimmune cause of liver inflammation.
What do positive results in the Liver Kidney Microsomal IgG Antibody test indicate?
A positive result indicates the presence of antibodies against liver and kidney microsomes in the blood. This is typically associated with AIH type 2. However, a positive result should be interpreted in conjunction with other clinical findings, lab tests, and patient history.
Can a person have AIH type 2 with a negative Liver Kidney Microsomal IgG Antibody test?
While the Liver Kidney Microsomal IgG Antibody test is a useful tool for diagnosing AIH type 2, a negative result does not completely rule out the disease. Other diagnostic tests and clinical evaluations are necessary to confirm or rule out the diagnosis.
How do the results of the Liver Kidney Microsomal IgG Antibody test influence clinical management?
Positive results can confirm the diagnosis of AIH type 2, leading to specific treatments such as immunosuppressive therapy. It can also help physicians differentiate between AIH type 2 and other types of liver disease, ensuring appropriate treatment and monitoring.
What other tests might be ordered alongside the Liver Kidney Microsomal IgG Antibody test?
The Liver Kidney Microsomal IgG Antibody test might be ordered alongside other tests, including liver function tests (such as ALT, AST, ALP, and bilirubin), other antibody tests (like antinuclear antibodies or smooth muscle antibodies), and imaging tests, to get a comprehensive view of liver health and function.
Are there other conditions that might produce a positive Liver Kidney Microsomal IgG Antibody test result?
Yes, while AIH type 2 is the most common condition associated with positive results, other diseases, such as certain drug reactions or viral infections, might produce a positive result. However, these are less common, and the presence of these antibodies is highly suggestive of AIH type 2.
How does AIH type 2, indicated by a positive Liver Kidney Microsomal IgG Antibody test, relate to other types of autoimmune hepatitis?
AIH type 2 is just one subtype of autoimmune hepatitis. The presence of liver kidney microsomal antibodies differentiates it from AIH type 1, which is associated with antinuclear antibodies (ANA) and smooth muscle antibodies (SMA). The two types have different clinical presentations, and their management might differ slightly, making the differentiation important.
We advise having your results reviewed by a licensed medical healthcare professional for proper interpretation of your results.